Clinical trials: Subjective Tinnitus
Chronic Subjective Tinnitus
Study of BGG492 in Patients With Chronic Subjective Tinnitus
This study will assess the efficacy of a two week treatment with BGG492 in patients with chronic subjective Tinnitus.
- Trial name
- NCT01302873
- Testing
- BGG492A
- Where
- 4 sites in Germany, Netherlands
- Volunteers
- 96 people
- Sponsor
- Novartis Pharmaceuticals
Tinnitus, Subjective
Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo
This study aims to demonstrate that the new medicine AUT00063 is effective and safe in the treatment of tinnitus.
- Trial name
- QUIET-1 (NCT02315508)
- Testing
- AUT00063
- Where
- 18 sites in United Kingdom
- Volunteers
- 91 people
- Sponsor
- Autifony Therapeutics Limited
Subjective Tinnitus
Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.
- Trial name
- EASE (NCT00739635)
- Testing
- Neramexane mesylate
- Where
- 54 sites in Austria, Germany and 3 more
- Volunteers
- 411 people
- Sponsor
- Merz Pharmaceuticals GmbH
Subjective Tinnitus
Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
The purpose of this study is to investigate the long-term safety and tolerability and efficacy of neramexane mesylate in the long-term treatment of subjective tinnitus after a completed double-blind randomized placebo controlled…
- Trial name
- OLLTT (NCT00827008)
- Testing
- Neramexane mesylate
- Where
- 135 sites in United States, Austria and 12 more
- Volunteers
- 821 people
- Sponsor
- Merz Pharmaceuticals GmbH
Subjective Tinnitus
Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.
- Trial name
- NCT00955799
- Testing
- Neramexane mesylate
- Where
- 76 sites in United States, Austria and 3 more
- Volunteers
- 455 people
- Sponsor
- Merz Pharmaceuticals GmbH
Subjective Tinnitus
Evaluation of Low Dose Laser in Treatment of Tinnitus
The purpose of this study is to determine wether low dose laser is effective on idiopathic subjective tinnitus.
- Trial name
- NCT01268449
- Testing
- Low dose laser
- Volunteers
- 66 people
- Sponsor
- Islamic Azad University of Mashhad
Subjective Tinnitus
Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.
- Trial name
- NCT00772980
- Testing
- Neramexane mesylate
- Where
- 56 sites in Belgium, Czechia and 4 more
- Volunteers
- 400 people
- Sponsor
- Merz Pharmaceuticals GmbH
Subjective Tinnitus
Effect of Gabapentin on Idiopathic Subjective Tinnitus
The purpose of this study is to determine wether Gabapentin which is useful for treating neuropathic pains, is effective on idiopathic subjective tinnitus.
- Trial name
- NCT00555776
- Testing
- Gabapentin
- Where
- Iran
- Volunteers
- 70 people
- Sponsor
- Islamic Azad University of Mashhad